|
Market Closed -
Deutsche Boerse AG
07:06:15 17/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 11.94 EUR | +2.05% |
|
0.00% | +127.65% |
| 09-15 | French and Benelux stocks-Factors to watch on September 15 | RE |
| 09-15 | France's Genfit Plans Phase 2a Trial of Liver Failure Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 45.91B | |||||
| 44.25B | |||||
| 41.99B | - | - | - | - | - |
| 39.58B | |||||
| 31.08B |
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
- Charts GENFIT
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
